We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge OKs Glaxo's $75M Settlement Over Alleged Relafen Evergreening

Law360 (December 2, 2004, 12:00 AM EST) -- A federal judge has tentatively approved a $75 million settlement agreement between GlaxoSmithKline PLC and a group of consumers and third-party payors who claimed the U.K. drug maker broke antitrust law...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.